Skip to main content

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, you consent to the use of these cookies.

Okay
Welcome to the new updated XLHLink.com!
  • Connect the symptoms of XLH

    Connect the symptoms.
    Is it XLH?

    Connect the symptoms of XLH
  • Doctor with a stethoscope viewing a file, face and upper torso only

    Understand how to manage XLH

    Actor portrayal

  • Group of 4 people having a conversation

    Explore resources for you and your patients

    Actor portrayal

XLH is rare1

X-linked hypophosphatemia (XLH) is a lifelong, primarily hereditary disease characterized by chronic hypophosphatemia due to increased fibroblast growth factor 23 (FGF23) activity2,3

Icon of a DNA helix representing the hereditary nature of XLH

Hereditary

XLH is primarily an inherited condition, which means it runs in families.3

Two arrows crossing each other representing the progressive nature of XLH

Progressive

New symptoms of XLH may appear as patients get older and can worsen or change over time.4

Infinity symbol representing the chronic nature of XLH

Chronic

Individuals with XLH can continue to experience symptoms throughout their lives.4

Discover the cause Discover child symptoms Discover adult symptoms

Take action to help your patients

Icon of an eye

Suspect XLH?

Connect their symptoms and accurately diagnose with the right tests.

Recognize the signs
Icon of a gear

Manage XLH

Manage XLH early to prevent progressive bone damage.

Find treatment options
Icon of a magnifying glass and browser search bar

XLH resources and community

From case studies to brochures, find resources for you and your patients to understand more about this rare condition.

HCP resources Patient resources
Stay connected

Set up time with a representative to talk more about XLH, or sign up for news and information about XLH.

Request a rep Sign up

References:

1. Giannini S, Bianchi ML, Rendina D, Massoletti P, Lazzerini D, Brandi ML. Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review. Osteoporos Int. 2021;32(10):1937-1949. doi:10.1007/s00198-021-05997-1 2. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381-1388. doi:10.1002/jbmr.340 3. Ruppe MD. X-linked hypophosphatemia. In: Adam MP, Everman DB, Mirzaa GM, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; February 9, 2012. Updated April 13, 2017. https://www.ncbi.nlm.nih.gov/books/NBK83985/ 4. Skrinar A, Dvorak-Ewell M, Evins A, et al. The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocr Soc. 2019;3(7):1321-1334. doi:10.1210/js.2018-00365